The Winlevi Way

Models shown are not actual patients.

A first-in-class mechanism to target androgen receptors in acne vulgaris1,2*

Male & Female
12+

WINLEVI (clascoterone) cream 1% is an androgen receptor inhibitor indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

*The exact mechanism of WINLEVI in acne vulgaris is unknown.1

Discover savings for eligible commercially insured patients

Learn More
A different way to treat acne    •

FDA-approved WINLEVI is the first novel topical mechanism for acne in nearly 40 years2-4*

Targeting the effects of hormones in the skin


As you know, androgen hormones can cause acne in both males and females by stimulating sebum production and inflammation.5 But a topical androgen receptor inhibitor didn’t exist, until now. First-in-class WINLEVI (clascoterone) cream 1% is an FDA-approved novel topical androgen receptor inhibitor appropriate for use in both male and female patients.1-4*

*The exact mechanism of WINLEVI in acne vulgaris is unknown.1

WINLEVI is not like other acne treatments. Topical WINLEVI treats acne differently. And that could make a real difference to your patients.

Models shown are not actual patients.

Inhibits effects of androgen hormones on cells in sebaceous glands1,3,6*
Significantly reduces inflammatory and noninflammatory lesions1,3
7% to 12% of patients experienced erythema/reddening, pruritus and scaling/dryness1,3†
Less than 2% of patients experienced systemic side effects3‡
Approved for male and female patients aged 12 and up1,3

Additionally, edema, stinging, and burning occurred in >3% of patients and were reported in a similar percentage of subjects treated with vehicle.

Hypothalamic-pituitary-adrenal (HPA) axis suppression may occur during or after treatment with WINLEVI. Attempt to withdraw use if HPA axis suppression develops.

MOA the WINLEVI Way

WINLEVI targets androgen component of acne in male and female patients*

Learn More

*The exact mechanism of WINLEVI in acne vulgaris is unknown.1

Efficacy the WINLEVI Way

WINLEVI provides you with another option in your treatment approach

See the results

Models shown are not actual patients.